Routine Monitoring of Isometric Knee Extension Strength in Patients with Muscle Impairments Using a New Portable Device: Cross-validation Against a Standard Isokinetic Dynamometer
Overview
Biophysics
Physiology
Affiliations
Objective: Muscle strength is a critical clinical hallmark in both health and disease. The current study introduces a novel portable device prototype (MyoQuad) for assessing and monitoring maximal voluntary isometric knee extension torque (MVIT).
Approach: Fifty-six patients with inclusion body myositis were studied. Knee extension weakness is a key feature in this inflammatory muscle disease. Cross-validation with an isokinetic dynamometer (Biodex System 3 Pro) was performed. Between-day reproducibility and ability to monitor changes in muscle strength over time compared to the gold standard method as a reference, were also investigated.
Main Results: The measurement was feasible even in the weakest patients. Agreement between methods was excellent (standard error of measurement (SEM) was 3.8 Nm and intra-class correlation coefficient (ICC) was 0.973). Least significant difference (LSD) was 4.9 and 5.3 Nm for the MyoQuad and the Biodex, respectively Measurements using the MyoQuad exhibited excellent between-day reproducibility (SEM was 2.4 Nm and ICC was 0.989 versus 2.6 Nm and 0.988 using the Biodex). Changes in MVIT at 6 and 12 months were similar between methods (timepoint × method interaction was not significant; all p > 0.19); strength changes classified according to LSD at 6 and 12 months were consistent between methods (>70% consistent classification)).
Significance: The measurement of MVIT using the MyoQuad offers a cost-effective, portable and immediate alternative for the routine measurement of maximal voluntary isometric strength of the quadriceps. The MyoQuad offers a comfort and stability that cannot be provided by standard hand-held dynamometers. These results support quantitative muscle strength assessment using fixed yet flexible dynamometry within clinical routine and multicenter trials.
Alahmari K, Reddy R Heliyon. 2024; 10(20):e39270.
PMID: 39498014 PMC: 11533566. DOI: 10.1016/j.heliyon.2024.e39270.
Santos D, Bravo-Sanchez A, Peyre-Tartaruga L, Simini F, Zacca R Sports (Basel). 2024; 12(10).
PMID: 39453234 PMC: 11511426. DOI: 10.3390/sports12100268.
Andrades-Ramirez O, Ulloa-Diaz D, Castillo B, Arroyo-Jofre P, Castillo-Paredes A, Chirosa-Rios L Sports (Basel). 2024; 12(7).
PMID: 39058066 PMC: 11280515. DOI: 10.3390/sports12070175.
Park S, Myong Y, Cho M, Cho S, Lee W, Oh B Sci Rep. 2024; 14(1):10428.
PMID: 38714762 PMC: 11076506. DOI: 10.1038/s41598-024-60985-9.
Cho S, Myong Y, Park S, Cho M, Kim S Sci Rep. 2023; 13(1):22221.
PMID: 38097727 PMC: 10721896. DOI: 10.1038/s41598-023-49263-2.